Marker Therapeutics (MRKR) Other Non Operating Income (2010 - 2026)
Marker Therapeutics (MRKR) reported Other Non Operating Income of $8677.0 for Q1 2026, down 92.61% quarter-over-quarter from $117444.0 in Q2 2025.
Marker Therapeutics (MRKR) Other Non Operating Income (2010 - 2026) Analysis & Trends
Marker Therapeutics (MRKR) has 13 years of Other Non Operating Income data on file, last reported at $8677.0 in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $8677.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $126121.0 (changed N/A YoY), and the FY2025 annual result was $117444.0, changed N/A from the prior year.
- Other Non Operating Income fell to $8677.0 in Q1 2026 per MRKR's latest filing, from $117444.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $117444.0 in Q2 2025 and troughed at $8677.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,677.00 |
| Jun 30, 2025 | 117,444.00 |
| Mar 31, 2020 | 31,000.00 |
| Dec 31, 2019 | 98,000.00 |
| Sep 30, 2019 | -64,000.00 |
| Jun 30, 2019 | -7,000.00 |
| Mar 31, 2019 | -9,000.00 |
| Dec 31, 2018 | 58,000.00 |
| Sep 30, 2018 | 40,000.00 |
| Jun 30, 2018 | -139,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Jun 30, 2017 | 7,500.00 |
| Mar 31, 2017 | -3,000.00 |
| Dec 31, 2016 | 14,500.00 |
| Mar 31, 2016 | -3.00 Mn |
| Dec 31, 2015 | 28.49 Mn |
| Sep 30, 2015 | 30.27 Mn |
| Jun 30, 2015 | -59.08 Mn |
| Mar 31, 2015 | 327,440.00 |